Passive immunity in prevention and treatment of infectious diseases

Clinical Microbiology Reviews

Volumn 13, Issue 4, 2000, Pages 602-614

  Keller, M A ^a   Stiehm, E R ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BOTULINUM ANTISERUM; DIPHTHERIA ANTIBODY; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; PALIVIZUMAB; PERTUSSIS IMMUNOGLOBULIN G; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; TETANUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

BACTERIAL INFECTION; CLINICAL TRIAL; CLOSTRIDIUM; DIPHTHERIA; EBOLA VIRUS; ENTEROVIRUS; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MEASLES VIRUS; NONHUMAN; PARVOVIRUS; PASSIVE IMMUNIZATION; PERTUSSIS; PSEUDOMONAS; RABIES VIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RUBELLA VIRUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; TETANUS; VACCINIA; VIRUS INFECTION;

ANIMAL; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; BACTERIAL INFECTIONS; HUMAN; IMMUNIZATION, PASSIVE; VIRUS DISEASES;

EID: 0033793926     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.13.4.602-614.2000     Document Type: Review

References (200)

1. Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome
2. Neonatal enterovirus infection: Virology, serology, and effects of intravenous immune globulin
3. TBE - Immunoglobulins: A critical assessment of efficacy
4. Treatment of Haemophilus influenzae infection and of meningococcic and pneumococcic meningitis
5. Severe invasive group A streptococcal infections: A subject review
6. Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IGIV
7. Respiratory syncytial virus immune globulin intravenous: Indications for use
8. Varicella-zoster virus
9. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates
10. Treatment of pertussis with pertussis immune globulin
11. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases
12. Vaccinia gangrenosa treated with hyperimmune vaccinal gamma globulin
13. Intravenous immunoglobulin therapy for toxic-shock syndrome
14. Efficacy of immune globulin in preventing complications of bone marrow transplantation: A meta-analysis
15. Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid
16. Failure of intrathecal tetanus antitoxin in the treatment of tetanus neonatorum
17. Use of convalescent blood in whooping cough
18. Treatment of severe pertussis: A study of the safety and pharmacology of intravenous pertussis immunoglobulin
19. Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model
20. Cytomegalovirus infection in kidney transplantation: Prophylaxis and management
21. Treatment of gram negative shock with human IgG antibody to Escherichia coli J5: A prospective, double-blind, randomized trial
22. Passive antibody therapies: Progress and continuing challenges
23. Return to the past: The case for antibody-based therapies in infectious diseases
24. Postexposure prophylaxis of hepatitis B
25. Recommendations for protection against viral hepatitis
26. Vaccinia (smallpox) vaccine recommendations of the immunization practices Advisory Committee (ACIP)
27. Human rabies prevention - United States, 1999. Recommendations of Advisory Committee (ACIP)
28. Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis
29. Successful treatment of persistent erythroid aplasia caused by parvovirus B19 infection in a patient with common variable immunodeficiency with low-dose immunoglobulin
30. INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis
31. Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species
32. Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential
33. Successful treatment of Epstein-Barr virus infection with ganciclovir and cytomegalovirus hyperimmune globulin following kidney transplantation
34. Immunoprophylaxis against Klebsiella and Pseudomonas aeruginosa infections
35. Intraventricular gamma-globulin for the management of enterovirus encephalitis
36. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation
37. The efficacy of vaccinial immune globulin, a 15-year study
38. Fulminant Epstein-Barr viral hepatitis: Orthotopic liver transplantation and review of the literature
39. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulin after liver transplantation
40. Immune-mediated hematologic and oncologic disorders, including Epstein-Barr virus infection
41. Opsonic antibodies to Staphylococcus epidermidis: In vitro and in vivo studies using human intravenous immune globulin
42. Varicella-zoster
43. Synergism between human gamma globulin and chloramphenicol in the treatment of experimental bacterial infections
44. Intravenous immunoglobulin prophylaxis of cytomegalovirus infection in pediatric renal transplant recipients
45. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable cause of anemia with AIDS
46. Outcomes among pediatric heart transplant recipients after dual-therapy cytomegalovirus prophylaxis
47. Clinical immunology and infectious diseases
48. The use of human immune serum globulin (gamma globulin) in infectious (epidemic) hepatitis in the Mediterranean theater of operations. I. Studies on prophylaxis in two epidemics of infectious hepatitis
49. Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins
50. Monoclonal antibodies against respiratory syncytial virus
51. Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma
52. Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients - A meta-analysis
53. Specific immunoglobulin for treatment of whooping cough
54. Liver transplantation in HB(s)Ag-positive HBV-DNA-negative cirrhotics: Immunoprophylaxis and long-term outcome
55. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children
56. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG)
57. Immune globulin therapy in allogeneic bone marrow transplant: A critical review
58. Intrathecal human tetanus immunoglobulin in early tetanus
59. Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin
60. Cytomegalovirus prophylaxis with ganciclovir, acyclovir, and CMV hyperimmune globulin in liver transplant patients receiving OKT3 induction
61. Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii
62. Prevention of infectious hepatitis with gamma globulin
63. 2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt
64. A family of selective immunodeficiency with normal immunoglobulins: Possible autosomal dominant inheritance
65. Treatment of severe pertussis by administration of specific gamma globulin with high titers anti-toxin antibody
66. Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection
67. Conservative management of an echovirus 11 outbreak in a neonatal unit
68. Neonatal coxsackie virus group B infections: Experience of a single Department of Neonatalogy
69. Successful intravenous immunoglobulin therapy for recurrent pneumococcal otitis media in young children
70. Passive immunotherapy in the treatment of advanced human immunodeficiency virus infection
71. Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses
72. Evaluation of immune globulin and recombinant interferon-α2b for treatment of experimental Ebola virus infections
73. Clinical practice guidelines: Prevention of cytomegalovirus disease after renal transplantation
74. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis
75. The role of intravenous immunoglobulin for the prevention and treatment of neonatal sepsis
76. Intravenous immunoglobulin in disseminated neonatal echovirus 11 infection
77. Treatment of intensive care unit patients with severe nosocomial infections
78. Role of infection in mortality from severe burns: Evaluation of plasma, gamma globulin, albumin, and saline solution therapy in a group of Peruvian children
79. Studies on smallpox and complications of smallpox vaccination
80. The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox
81. Progressive vaccinia treated with ribavirin and vaccinia immune globulin
82. Risk factors associated with Echovirus 11 infection in a hospital nursery
83. Efficacy of prophylactic gamma-globulin in preventing non-A non-B post transfusion hepatitis
84. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: Use of intravenous immunoglobulin - A report of eight patients
85. Successful treatment of echovirus meningoencephalitis in sex-linked agammaglobulinaemia by intrathecal and intravenous injection of high titer gammaglobulin
86. Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections
87. Administration of intravenous immunoglobulins for prophylaxis or treatment of infection in preterm infants: Meta-analysis
88. Clinical usefulness of intravenous human immunoglobulins in invasive group A streptococcal infections: Case report and review
89. Anti-tetanus toxoid antibodies in intravenous gamma globulin: An alternative to tetanus immune globulin
90. Use of intravenous immunoglobulin to prevent or treat infections in persons with immune deficiency
91. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin
92. Passive hyperimmune plasma therapy in the treatment of acquired immunodeficiency syndrome: Results of a 12-month multicenter double-blind controlled trial
93. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSF F protein
94. Human parvovirus B19 infection in organ transplant recipients
95. Recombinant human monoclonal antibodies to Ebola virus
96. Intravenous immunoglobulins suppress the recurrences of genital herpes simplex virus: A clinical and immunological study
97. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients
98. Vaginal tampon model for toxic shock syndrome
99. Efficacy of hyperimmune anti-cytomegalovirus immunoglobulins for the prevention of cytomegalovirus infection in recipients of allogeneic bone marrow transplantation: A meta-analysis
100. Chronic enteroviral meningoencephalitis, in agammaglobulinemia: Case report and literature review
101. 9/L or more: Effect on viral, opportunistic, and bacterial infections
102. Failure of hyper-immune globulin to prevent whooping cough
103. Liver transplantation in HB(s) antigen (HBsAg) carriers: Prevention of hepatitis B virus (HBV) recurrence by passive immunization
104. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients
105. Use of normal immunoglobulin in an echovirus 11 outbreak in a special-care baby unit
106. Prophylactic effect of antivaccinia gamma-globulin against post-vaccinial encephalitis
107. The French National Registry of HA-1A (Centoxin) in septic shock. A cohort study of 600 patients
108. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection
109. Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalovirus-infected fetus
110. Hyperimmunoglobulin therapy for a twin fetus with cytomegalovirus infection and growth restriction
111. Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: Implications for therapeutic efficacy
112. Disorders of the B-cell system
113. Treatment with ganciclovir and Ig for acute Epstein-Barr virus infection after allogeneic bone marrow transplantation
114. Toxic shock syndrome after staphylococcal pneumonia treated with intravenous immunoglobulin
115. Antiviral prophylaxis and treatment in chickenpox, a review prepared for the UK Advisory Group on chickenpox on behalf of the British Society for the Study of Infection
116. Immunovirological studies of fatal infectious mononucleosis in a patient with X-linked lymphoproliferative syndrome treated with intravenous immunoglobulin and interferon-α
117. Immunotherapy of CMV infections
118. Nonmenstrual toxic shock syndrome: New insights into diagnosis, pathogenesis and treatment
119. Intravenous immunoglobulin prophylaxis in an echovirus 6 and echovirus 4 nursery outbreak
120. Cytomegalovirus prophylaxis in solid organ transplant recipients
121. Role of immunoglobulin and new antivirals in treatment of cytomegalovirus infection
122. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: Case report and review
123. Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin
124. Elimination of cytomegalovirus disease in liver transplant patients treated prophylactically with combination cytomegalovirus hyperimmune globulin and ganciclovir
125. Outbreak of echovirus 11 infection in hospitalized neonates
126. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants
127. Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants
128. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group
129. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children
130. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients
131. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis
132. HBV-infection in liver transplantation in HB(s)Ag positive patients: Experience with long-term immunoprophylaxis
133. Liver transplantation in European patients with the hepatitis B surface antigen
134. Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients
135. Prevention of Haemophilus influenzae type b infections in high risk infants treated with bacterial polysaccharide immune globulin
136. Transmission of viral infections through intravenous immune globulin
137. Immunoglobulins in the prophylaxis of parvovirus B19 infection
138. Parvovirus B19 infection during pregnancy treated with high-dose intravenous gammaglobulin
139. Botulism in the United States: A clinical and epidemiologic review
140. Experience of anti-vaccinia immunoglobulin in the United Kingdom
141. Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children
142. Reduction in transplant-related complications in patients given intravenous immune globulin after allogeneic marrow transplantation
143. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children
144. Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease
145. Prevention of non-A, non-B hepatitis in haemodialysis patients by hepatitis B immunoglobulin
146. Use of acyclovir for varicella pneumonia during pregnancy
147. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients
148. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection
149. Zoster immune globulin prophylaxis of disseminated zoster in compromised hosts
150. Appropriate therapeutic use of immunoglobulin
151. Use of human immunodeficiency virus-intravenous immunoglobulin (HIV-IVIG) in HIV-1 infected children (Pediatric AIDS Clinical Trials Group Protocol 273)
152. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185
153. Summary of the workshop on passive immunotherapy in the prevention and treatment of HIV infection. The Passive Antibody Workshop Participants
154. The prevention and attenuation of infectious hepatitis by gamma globulin
155. Humanized monoclonal antibody for prevention of respiratory syncytial virus infection
156. The effect of intravenous immunoglobulin and interferon-alpha on Epstein-Barr virus-induced lymphoproliferative disorder in a liver transplant recipient
157. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant
158. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin
159. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
160. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis
161. 1 infection
162. Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis
163. Humanized antibodies as potential therapeutic drugs
164. Passive immunotherapy in AIDS: A double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus-1 antibodies vs. Transfusions of seronegative plasma
165. Vaccination against tick-borne encephalitis (TBE): Influence of simultaneous application of TBE immunoglobulin on seroconversion and rate of adverse events
166. The treatment of bacterial infections with the combination of antibiotics and gamma globulin
167. Severe tick-borne encephalitis following passive immunization
168. Etiology, epidemiology and prevention of viral hepatitis
169. Intranasal antibody prophylaxis for protection against viral disease
170. Treating patients with severe sepsis
171. Combination therapy with aeroslized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients
172. Neonatal herpes simplex virus infections: Is there a role for immunoglobulin in disease prevention and therapy?
173. Treatment of Clostridium difficile infection
174. Failure of postexposure treatment of rabies in children
175. The physiologic immunodeficiency of immaturity
176. Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis
177. Reference deleted
178. Meta-analysis of CMVIG studies for the prevention and treatment of CMV infection in transplant patients
179. Parvovirus infection and its treatment
180. Prevention and treatment of cytomegalovirus pneumonia in transplant recipients
181. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli
182. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT)